The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

16 Jan 2018 07:00

RNS Number : 9289B
InnovaDerma PLC
16 January 2018
 

LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

 ("InnovaDerma" or the "Company")

Trading Update and Notice of Results

InnovaDerma (LSE: IDP), a UK developer of life sciences, beauty and personal care products, is pleased to provide a trading update for the six months ended 31 December 2017.

 

Revenue for the period increased by 31% on a constant currency basis to £4.2m (H1 FY2016: £3.2m) with excellent Direct to Consumer ("DTC") performance, particularly from Skinny Tan in the UK, and good progress in securing new retail accounts during the period. The Board of InnovaDerma is particularly pleased with the Roots™ Double Effect ("Roots") haircare range, launched in August 2017, which was developed in house and deployed through its DTC channel to create demand online and offline. Roots is growing in popularity and has performed strongly in the period under review.

 

Skinny Tan's growth is expected to continue at an accelerated pace derived from both DTC and key retail partners with the continued launch of new product extensions in the second half of the year to leverage the brand's popularity. As planned, a number of the Company's other cosmetic, skincare and life sciences brands are expected to be introduced in various geographical territories during 2018.

 

As in prior years and as stated at the time of the final results in September, the Company expects revenue and profit growth to be strongly weighted to the second half. This reflects the momentum created in the first half as peak tanning season approaches. In addition, entry into new markets together with new product launches such as Roots, Charles + Lee, StevieK Cosmetics and Prolong are expected to feed through to substantial revenue and profit growth in the second half of the year.

 

The Board remains confident in meeting market expectations for the current financial year and has much greater revenue visibility for the second half than in prior years.

 

The Company will announce its results for the six months ended 31 December 2017 on 15 February 2018.

 

InnovaDerma

Haris Chaudhry/Joe Bayer

+61 (0)3 9111 0071

finnCap Ltd

Geoff Nash/Kate Bannatyne

Alice Lane - Corporate Broking

+44 (0) 20 7220 0500

www.finncap.com

Cardew Group

Shan Shan Willenbrock

David Roach

Joe McGregor

 

+ 44 (0)20 7930 0777

About InnovaDerma

InnovaDerma PLC (LSE: IDP) specializes in the research, manufacture and marketing of clinically proven products in life sciences, beauty and personal care products. InnovaDerma has presence in Europe, US, Australasia, Asia and Africa. 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFKPDBABKDQDD
Date   Source Headline
5th May 20172:05 pmRNSSecond Price Monitoring Extn
5th May 20172:00 pmRNSPrice Monitoring Extension
3rd May 20172:06 pmRNSSecond Price Monitoring Extn
3rd May 20172:00 pmRNSPrice Monitoring Extension
3rd May 20177:15 amRNSCompany update and Directorate Change
2nd May 20177:00 amRNSAcquisition
28th Apr 20178:05 amRNSBroker Warrants
11th Apr 20177:00 amRNSAllotment of Shares
3rd Apr 20177:00 amRNSTrading update
3rd Mar 20174:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20174:35 pmRNSPrice Monitoring Extension
3rd Mar 20172:05 pmRNSSecond Price Monitoring Extn
3rd Mar 20172:00 pmRNSPrice Monitoring Extension
2nd Mar 201711:18 amRNSExercise of Share Options
1st Mar 20177:00 amRNSCompletion of Acquisitions
27th Feb 20177:00 amRNSAcquisition of Stevie K and Charles + Lee Brands
9th Feb 20177:00 amRNSHalf-year Report
30th Jan 20177:00 amRNSDirectorate Change
27th Jan 201711:17 amRNSNotice of Results
25th Jan 20178:00 amRNSHeads of Agreement with PROS Korea
16th Jan 20177:00 amRNSTrading Statement
10th Jan 20177:00 amRNSDirectorate Change
9th Jan 20179:06 amRNSSecond Price Monitoring Extn
9th Jan 20179:00 amRNSPrice Monitoring Extension
19th Dec 20163:18 pmRNSHolding(s) in Company
15th Dec 201610:08 amRNSResult of AGM
14th Dec 20169:45 amRNSPlacing
8th Dec 20167:00 amRNSCompletion of Placing
6th Dec 20167:30 amRNSGeneral Manager appointed for the UK and Europe
25th Nov 20167:00 amRNSPlacing and Fundraising
17th Nov 20164:34 pmRNSNotice of AGM & Posting of Annual Report
16th Nov 20161:54 pmRNSBroker Warrants
14th Nov 20167:00 amRNSPublication of Supplementary Prospectus
11th Nov 201611:23 amRNSDirector/PDMR Shareholding
31st Oct 201610:25 amRNSFinal Results
31st Oct 20167:00 amRNSInnovaDerma enters US market
24th Oct 20167:00 amRNSOperational update & presentation published online
21st Oct 20162:15 pmRNSIssue of Equity
20th Oct 201611:05 amRNSSecond Price Monitoring Extn
20th Oct 201611:00 amRNSPrice Monitoring Extension
10th Oct 20167:00 amRNSTrading Statement
9th Sep 201612:38 pmRNSVoluntary Suspension of Trading on Marche Libre
7th Sep 20167:00 amRNSAdmission to the Official List

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.